Rovi slips as CVC is said to be only suitor left for its manufacturing business

Laboratorios Farmaceuticos Rovi

10/09/2024 10:21

** Shares in Rovi  ROVI.MC  slip 4% after a report said that
CVC  CVC.AS  remains the only potential suitor for a majority
stake in the company's manufacturing business
        ** Spanish Expansion newspaper said CVC is the only
bidder left for the stake in the unit, which is worth more than
3 billion euros ($3.31 billion), after other potential investors
who had filed non-binding offers withdrew from the process
  
    ** Spokespeople at Rovi and CVC did not immediately respond
to requests for comment
    ** "Previously there were several other candidates," Renta 4
analysts say
    ** They also note that the price could be lower due to the
dependence on Moderna and that Rovi could be required to remain
a shareholder
    ** Up to the previous session's close, shares were up 37%​
YTD
    ** CVC is down 0.2%

($1 = 0.9057 euros)

 (Reporting by Matteo Allievi)
 ((Matteo.allievi@thomsonreuters.com))